A detailed history of Raymond James & Associates transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Raymond James & Associates holds 383,355 shares of XBI stock, worth $35 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
383,355
Previous 355,844 7.73%
Holding current value
$35 Million
Previous $33 Million 14.81%
% of portfolio
0.02%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$90.87 - $102.43 $2.5 Million - $2.82 Million
27,511 Added 7.73%
383,355 $37.9 Million
Q2 2024

Jul 19, 2024

SELL
$82.22 - $94.12 $5.17 Million - $5.92 Million
-62,860 Reduced 15.01%
355,844 $33 Million
Q1 2024

Apr 22, 2024

BUY
$87.05 - $102.89 $8.97 Million - $10.6 Million
103,077 Added 32.66%
418,704 $39.7 Million
Q4 2023

Jan 16, 2024

BUY
$64.12 - $90.86 $1.66 Million - $2.35 Million
25,856 Added 8.92%
315,627 $28.2 Million
Q3 2023

Oct 24, 2023

SELL
$71.88 - $85.76 $1.08 Million - $1.29 Million
-15,091 Reduced 4.95%
289,771 $21.2 Million
Q2 2023

Jul 25, 2023

SELL
$75.38 - $90.23 $1.41 Million - $1.69 Million
-18,711 Reduced 5.78%
304,862 $25.4 Million
Q1 2023

Apr 14, 2023

SELL
$73.13 - $91.97 $1.47 Million - $1.84 Million
-20,042 Reduced 5.83%
323,573 $24.7 Million
Q4 2022

Feb 08, 2023

BUY
$76.72 - $85.66 $4.12 Million - $4.6 Million
53,758 Added 18.55%
343,615 $28.5 Million
Q3 2022

Oct 25, 2022

BUY
$75.06 - $94.9 $2.23 Million - $2.82 Million
29,748 Added 11.44%
289,857 $23 Million
Q2 2022

Aug 12, 2022

BUY
$62.81 - $96.09 $4.32 Million - $6.61 Million
68,837 Added 35.99%
260,109 $19.3 Million
Q1 2022

May 11, 2022

SELL
$81.07 - $115.44 $1.36 Million - $1.94 Million
-16,805 Reduced 8.08%
191,272 $17.2 Million
Q4 2021

Feb 08, 2022

BUY
$108.77 - $134.15 $1.86 Million - $2.29 Million
17,085 Added 8.95%
208,077 $23.3 Million
Q3 2021

Nov 02, 2021

SELL
$118.69 - $138.49 $1.43 Million - $1.67 Million
-12,058 Reduced 5.94%
190,992 $24 Million
Q2 2021

Aug 11, 2021

SELL
$122.48 - $139.69 $1.85 Million - $2.1 Million
-15,068 Reduced 6.91%
203,050 $27.5 Million
Q1 2021

May 14, 2021

BUY
$129.36 - $173.99 $542,277 - $729,366
4,192 Added 1.96%
218,118 $29.6 Million
Q4 2020

Feb 12, 2021

SELL
$110.36 - $151.14 $3.69 Million - $5.05 Million
-33,410 Reduced 13.51%
213,926 $30.1 Million
Q3 2020

Nov 04, 2020

SELL
$103.87 - $120.36 $1.33 Million - $1.54 Million
-12,799 Reduced 4.92%
247,336 $27.6 Million
Q2 2020

Jul 28, 2020

BUY
$73.26 - $114.17 $2.32 Million - $3.62 Million
31,704 Added 13.88%
260,135 $29.1 Million
Q1 2020

Apr 21, 2020

SELL
$65.95 - $98.35 $1.22 Million - $1.83 Million
-18,567 Reduced 7.52%
228,431 $17.7 Million
Q4 2019

Feb 12, 2020

BUY
$74.65 - $98.46 $431,327 - $568,901
5,778 Added 2.4%
246,998 $23.5 Million
Q3 2019

Nov 07, 2019

SELL
$76.25 - $83.86 $5.38 Million - $5.92 Million
-70,613 Reduced 22.64%
241,220 $18.4 Million
Q2 2019

Aug 06, 2019

SELL
N/A
-18,735 Reduced 5.67%
311,833 $27.4 Million
Q1 2019

May 06, 2019

SELL
N/A
-1,583 Reduced 0.48%
330,568 $29.9 Million
Q4 2018

Feb 11, 2019

SELL
N/A
-152,969 Reduced 31.53%
332,151 $23.8 Million
Q3 2018

Nov 14, 2018

BUY
N/A
52,868 Added 12.23%
485,120 $46.5 Million
Q2 2018

Aug 14, 2018

SELL
N/A
-2,905 Reduced 0.67%
432,252 $41.1 Million
Q1 2018

May 14, 2018

SELL
N/A
-10,322 Reduced 2.32%
435,157 $38.2 Million
Q4 2017

Feb 14, 2018

BUY
N/A
93,802 Added 26.67%
445,479 $37.8 Million
Q3 2017

Nov 13, 2017

BUY
N/A
48,631 Added 16.05%
351,677 $30.4 Million
Q2 2017

Aug 14, 2017

BUY
N/A
303,046
303,046 $23.4 Million

Others Institutions Holding XBI

About SPDR SER TR SPDR S&P BIOTECH E


  • Ticker XBI
  • Sector ETFs
  • Industry ETFs
More about XBI
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.